149 related articles for article (PubMed ID: 15481283)
1. How do we measure the effectiveness of inhaled corticosteroids in clinical studies?
Hansel TT
Respir Med; 2004 Oct; 98 Suppl B():S9-15. PubMed ID: 15481283
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence.
Vignola AM
Drugs; 2003; 63 Suppl 2():35-51. PubMed ID: 14984079
[TBL] [Abstract][Full Text] [Related]
3. Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.
Hirst C; Calingaert B; Stanford R; Castellsague J
J Asthma; 2010 May; 47(4):439-46. PubMed ID: 20528600
[TBL] [Abstract][Full Text] [Related]
4. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma.
Lipworth BJ; Jackson CM
Drugs; 2002; 62(16):2315-32. PubMed ID: 12396225
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
Creticos PS
Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
[TBL] [Abstract][Full Text] [Related]
8. Complementary therapy in asthma: inhaled corticosteroids and what?
Bjermer L; Diamant Z
Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
[TBL] [Abstract][Full Text] [Related]
9. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
10. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of long-acting beta agonists and inhaled corticosteroids in the management of chronic asthma.
Nelson HS
Curr Allergy Asthma Rep; 2005 Mar; 5(2):123-9. PubMed ID: 15683612
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
13. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
15. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
16. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
17. Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
Mori K; Fujisawa T; Inui N; Hashimoto D; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Imokawa S; Yamada T; Shirai T; Masuda M; Hayakawa H; Chida K; Suda T
Respir Med; 2016 Oct; 119():1-6. PubMed ID: 27692128
[TBL] [Abstract][Full Text] [Related]
18. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
19. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
20. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
